The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report
出版年份 2019 全文链接
标题
The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report
作者
关键词
-
出版物
ACTA ONCOLOGICA
Volume -, Issue -, Pages 1-4
出版商
Informa UK Limited
发表日期
2019-03-25
DOI
10.1080/0284186x.2019.1588992
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)
- (2018) Jame Abraham et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
- (2017) Laura M. Spring et al. ONCOLOGIST
- Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- (2017) Loay Kassem et al. Breast Cancer
- Impact of Screening on Survival in Familial Adenomatous Polyposis
- (2016) Laura Koskenvuo et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis
- (2015) Marco Fiore et al. EUROPEAN JOURNAL OF CANCER
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) ANNALS OF ONCOLOGY
- A systematic review of active treatment options in patients with desmoid tumours
- (2014) X. Yao et al. Current Oncology
- Desmoid-Type Fibromatosis and Pregnancy
- (2013) Marco Fiore et al. ANNALS OF SURGERY
- The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis
- (2013) Xiao-Ling Xu et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
- (2013) Mark A. Dickson et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- Signal transduction pathway analysis in desmoid-type fibromatosis: Transforming growth factor-β, COX2 and sex steroid receptors
- (2012) Nicholas A. Mignemi et al. CANCER SCIENCE
- Complete response to exemestane in a patient with a desmoid tumor
- (2012) Marc Debled et al. Future Oncology
- Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review
- (2011) D. Bocale et al. Colorectal Disease
- Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
- (2011) C. Thangavel et al. ENDOCRINE-RELATED CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now